Saturday, 2 November, 2024

16 Jul 2012 | Press Release

news > News and Events > Page 1

Nobel Biocare appoints Oliver Walker as Chief Financial Officer

Appointments and Promotions

Nobel Biocare announced today that Oliver Walker (43) has been appointed Chief Financial Officer and Member of the Executive Committee of Nobel Biocare.


He will take up his role at the beginning of August 2012. Oliver Walker is a senior finance executive with over 17 years of experience in international industrial settings, most of which were in the medtech industry. He brings expertise in leading the finance function of companies in dynamic industries with multi-faceted business models.

Oliver Walker spent seven years as CFO of Sonova, a publicly listed, leading hearing solutions company, and four years as CFO of Stratec Medical Group. Prior to Stratec, he worked for the industrial Von Roll Group in various management positions. Oliver Walker holds a Master of Science in Business Economics from the University of Berne, Switzerland.

Richard Laube, CEO of Nobel Biocare: "Oliver Walker brings significant expertise in finance, operational leadership and building scalable organizations. His strong project management and leadership skills and experience in building medical technology companies will be a great asset to Nobel Biocare as we continue to develop our company."

Related Contacts

Techniques

Clinical

Staying Safe

Clinical

Stream the latest dental videos...
Ridge Preservation – Step by Step

Sponsored Links...

Upcoming Events...

Nov 07 2024

Veneers: A Comprehensive Guide

Auckland, NEW ZEALAND

Nov 07 2024
Nov 10 2024
Nov 13 2024
Nov 24 2024

CBCT licensing course

Online via Zoom, AUSTRALIA

Nov 24 2024
Nov 29 2024
Dec 01 2024

2D Radiography interpretation course

Online via Zoom, AUSTRALIA

Dec 04 2024
Dec 08 2024
Dec 15 2024

CBCT licensing course

Online via Zoom, AUSTRALIA

Dec 15 2024
Mar 25 2025

IDS 2025

Cologne, GERMANY

May 08 2025
May 30 2025
Mar 20 2026
Apr 17 2026

IDEM Singapore 2026

Singapore, SINGAPORE